General Catalyst

Many manufacturers run on exceptions that their software can’t resolve, Fragment's agents resolve them end to end. Today, Fragment comes out of stealth with $56M in total funding. General Catalyst co-led their seed round, and are back to support their Series A. Listen to Pranav Mulgund and Naveen Kashyap discuss the procurement and economic impact of the iPhone in this short clip. cc: Vedant Suri, Yuri Sagalov

The names that built American manufacturing are iconic. Slater, who brought the mill. Lowell, who integrated it. Carnegie, who scaled steel. Ford, who set the line in motion. Deming, who taught the world quality. The forces of production that once built America are rebuilding America again. This is one of the most important economic and national security imperatives of our time. General Catalyst has backed Re:Build since 2024, and today we are co-leading their $2.1B round alongside JPMorganChase’s Strategic Investment Group.

Before starting Serval, Jake Stauch changed one question in his customer interviews. He asked IT teams what they would hand to someone hired to sit next to them and do their work. Almost everyone said the same thing. Building automations took longer than doing the task itself, which left them resetting passwords by hand, week after week. Serval automates the automations for every team that supports employees. Watch Marc Bhargava's full conversation with Jake: https://lnkd.in/gwiJJKkT

We’re quadrupling down on Legora's $550M Series E.   More than 140,000 legal professionals now do their work in Legora, spending about an hour and a half a day in the product. Law is one of the most supply-constrained industries in the world, and Legora is giving lawyers the capacity to meet more of that demand. Watch Jeannette's full conversation with Max Junestrand: https://lnkd.in/grnRGDJk

Baba is modernizing the last mile of healthcare for people on Medicare. Each person gets a dedicated advocate: a nurse, social worker, or benefits specialist equipped with AI. They book appointments, chase down benefits, and stay by each person’s side until they get the care they need. We’re proud to be deepening our partnership by doubling down in Baba’s $40M Series A. Watch Vedant Suri’s full conversation with Connor Sweeney: https://lnkd.in/gYWExTb3

"We can't claim our values if we can't defend them." Hypersonica exists because Europe needs to own its critical capabilities so no one can hold it hostage. Watch Jeannette zu Fürstenberg's full conversation with Philipp Kerth: https://lnkd.in/eAK-yNV6

In 1994, Peter Shor showed that a quantum computer could break modern encryption. For three decades, building one looked like it would take millions of physical qubits. This year, the team behind Oratomic proposed it could take as few as 10,000. We're doubling down by co-leading Oratomic’s Series B, bringing their total funding to $775M. Their fault-tolerant quantum computer has the potential to unlock new scientific capabilities and applications we have yet to imagine. Congratulations to Dolev Bluvstein and the team. Explore the future of quantum with Alexa Liautaud: https://lnkd.in/ePc2_qQE

The models that will accelerate drug discovery, chip design, and energy are limited by the data they learn from. We led Proximal's $15M seed as they build the data engine for the next generation of frontier AI and treat training data with the same rigor as model architecture. Watch Quentin's full conversation with Calvin: https://lnkd.in/gYVn-Fb7

Bringing a new drug to market in the United States cost under $1B in the 1990s. Today it costs approximately $3.5B, and every day a trial runs adds about $40,000. General Catalyst Institute President Maryam Mujica and Paradigm Health founder Kent Thoelke make the case for modernizing U.S. clinical trials: "We believe the countries that move fastest to build efficient, connected, patient-centered clinical research systems will shape the future of global healthcare, and have the healthiest people." Read their piece: https://lnkd.in/gCUSdWy2